Related by context. All words. (Click for frequent words.) 81 phase IIa clinical 79 Phase Ib clinical 79 phase IIa 78 phase IIb clinical 77 Phase Ib II 77 phase IIb 77 phase IIb trial 76 Phase IIa clinical 76 Phase IIb III 75 Phase IIb clinical 75 Phase Ib 75 Phase IIIb 75 Phase 1b clinical 75 Phase 2b trial 74 Phase IIa trial 74 Phase Ib study 74 Phase #b/#a 74 placebo controlled Phase III 74 Phase 2a clinical 74 Phase 2a trial 74 Phase #b/#a clinical 74 multicenter Phase II 74 Phase 1a clinical 74 oral ridaforolimus 74 Phase 2b clinical 74 dose escalation clinical 74 confirmatory Phase III 74 Phase IIB 74 MAGE A3 ASCI 74 multicenter clinical 74 alvespimycin 74 phase IIb III 73 oral deforolimus 73 phase Ib 73 Phase IIIb study 73 APEX PD 73 Phase 1b trial 73 MIST II 73 forodesine 73 Phase Ib IIa 73 randomized controlled Phase 73 Phase 2b kidney transplant 73 phase Ib clinical 73 Pivotal Phase III 73 Phase III randomized controlled 73 multicenter Phase 73 phase IIIb 73 BRIM3 73 Phase IIb trial 73 Phase Ia 73 vidofludimus 73 clinical pharmacology studies 73 placebo controlled clinical 72 registrational 72 TG MV 72 ACOMPLIA R 72 randomized Phase IIb 72 phase IIb study 72 RSD# oral 72 Phase III clinical 72 ADVANCE PD 72 ENDEAVOR III 72 budesonide foam 72 Phase 2b study 72 randomized multicenter Phase III 72 CUSTOM III 72 Phase IIa trials 72 pharmacokinetic PK study 72 OvaRex ® MAb 72 SUCCEED trial 72 Phase IIb trials 72 Phase IIb clinical trials 71 Phase III 71 elotuzumab 71 Phase IIb 71 initiate Phase IIb 71 lomitapide 71 Tarceva TM 71 Initiate Phase 71 Phase 1b 71 IIb clinical trial 71 NO# [002] 71 multicenter randomized placebo controlled 71 YONDELIS 71 FOLOTYN ® 71 Prostate AdenoCarcinoma Treatment 71 tramiprosate Alzhemed TM 71 Dacogen injection 71 Phase 1a 71 multicentre randomized 71 Combination REOLYSIN R 71 initiated Phase Ib 71 oral methylnaltrexone 71 Pivotal Trial 71 rALLy clinical trial 71 blinded randomized placebo controlled 71 assessing T DM1 71 relapsed MM 71 Androxal TM 70 refractory metastatic colorectal cancer 70 relapsing remitting MS RRMS 70 Phase 2a 70 Phase III Clinical Trial 70 IL# PE#QQR 70 HCV RESPOND 2 70 PSMA ADC 70 Phase III psoriasis 70 CLARITY study 70 TASKi3 70 Phase III pivotal 70 Cimzia TM 70 AIM HIGH 70 Raptiva ® 70 Phase 1b dose escalation 70 Phase 2b clinical trials 70 multicenter randomized controlled 70 Cloretazine ® 70 INCB# [001] 70 initiate Phase 2b 70 multicenter prospective 70 randomized Phase III 70 relapsed refractory multiple myeloma 70 BRIM2 70 Corlux 70 placebo controlled Phase 70 EndoTAG TM -1 70 Phase IIa 70 Aryplase 70 ZACTIMA 70 GetGoal Phase III 70 dose escalation Phase 70 metastatic hormone refractory 70 Phase #/#a 70 NSABP B 70 thorough QT 70 multicenter randomized clinical 70 ILLUMINATE 70 lumiliximab 70 multicenter phase 70 dirucotide 70 dose escalation phase 70 deforolimus 70 Amrubicin 70 tanespimycin 70 IIa trial 70 LUMINATE 70 dose cohort 70 JAK inhibitor 70 randomized Phase 2b 70 Bicifadine 69 multicenter Phase III 69 axitinib 69 Pivotal Clinical Trial 69 pivotal Phase III 69 EchoCRT 69 RE LY ® 69 Phase 1b clinical trials 69 Phase IIb kidney transplant 69 octreotide implant 69 omacetaxine mepesuccinate 69 SPIRIT FIRST 69 DASISION 69 catheter occlusion 69 ToGA 69 Traficet EN 69 Plicera 69 pivotal bioequivalence 69 Zenvia ™ 69 riociguat 69 acyclovir Lauriad R 69 severe hypercholesterolemia 69 Alvesco R 69 subcutaneous formulation 69 sunitinib malate 69 initiate Phase Ib 69 COMFORT II 69 interferon gamma 1b 69 zanolimumab 69 ENESTnd 69 IMA# 69 mg/m2 cohort 69 diabetic neuropathic pain 69 novel VDA molecule 69 EDEMA3 69 CALGB # [002] 69 Degarelix 69 AQ4N 69 CIMZIA TM certolizumab pegol 69 fostamatinib 69 Phase III Clinical Trials 69 Phase IIb Trial 69 SNT MC# 69 Phase #b/#a trial 69 Cloretazine R VNP#M 69 hoFH 69 brivaracetam 69 REBETOL combination therapy 69 Phase III HEAT 69 UPLYSO 69 ENDEAVOR IV 69 recurrent malignant glioma 69 PRE SURGE 69 TASKi2 69 registrational trial 69 ORENCIA ® 69 Plenaxis TM 69 Urocidin 69 GAMMAGARD 69 PFO migraine 69 lorvotuzumab mertansine 69 NP2 Enkephalin 69 Aflibercept 69 CR# vcMMAE 69 metastatic castration resistant 68 Asentar 68 Zenvia Phase III 68 CHAMPION PCI 68 LymphoStat B TM 68 confirmatory Phase 3 68 ITAX 68 EMPHASIS HF trial 68 ongoing Phase 1b 68 Personalized Immunotherapy 68 treatment naive genotype 68 EURIDIS 68 TLK# 68 Clolar ® 68 PREOS R 68 Allovectin 7 R 68 phase 2a 68 MEND CABG 68 DEB# 68 pertuzumab 68 ELACYT 68 STRIDE PD 68 BR.# 68 AZILECT ® 68 evaluating tivozanib 68 Pemetrexed 68 cannabinor 68 ANCHOR trial 68 ACAPODENE 68 KRN# 68 galiximab 68 Phase III VISTA 68 Golimumab 68 mertansine 68 RhuDex ® 68 registrational Phase 68 phase III isavuconazole 68 Pivotal Study 68 recurrent glioblastoma multiforme 68 Phase III Trial 68 HGS# 68 Fibrillex TM 68 trastuzumab DM1 68 AVADO 68 huC# DM4 68 SUTENT ® 68 HuMax EGFr 68 HCV SPRINT 68 THALOMID 68 ORENCIA R 68 Alzhemed TM 68 fosbretabulin 68 APEX AMI trial 68 PANVAC VF 68 Virulizin R 68 Pivotal Phase 68 relapsed multiple myeloma 68 Annamycin 68 rALLy trial 68 Meets Primary Endpoint 68 Targretin capsules 68 Loramyc R 68 neratinib 68 AZILECT R 68 Rebif ® 68 Quinamed 68 Daclizumab 68 goserelin 68 Tanespimycin 68 Phase III placebo controlled 68 MIVI III 68 PEG SN# 68 dose escalation trial 68 Randomized Phase 68 randomized controlled multicenter 68 midstage clinical 68 dirucotide MBP# 68 Azedra 68 multicenter placebo controlled 68 torezolid phosphate 68 confirmatory clinical 68 LEUKINE 67 double blinded placebo 67 placebo controlled randomized 67 crizotinib PF # 67 huN# DM1 67 acyclovir Lauriad ® 67 initiate Phase 1b 67 Advagraf 67 IMPACT IMmunotherapy 67 Viramidine 67 PXD# 67 Sibutramine Cardiovascular Outcomes 67 Archexin 67 Vectibix panitumumab 67 VNP#M 67 HuMax CD4 67 balsalazide tablet 67 LibiGel Phase III 67 canakinumab 67 Phase 2b 67 BLA filing 67 Raptiva R 67 teduglutide 67 Microplasmin 67 oral rivaroxaban 67 Intervention Effectiveness 67 SAR# [004] 67 Initiates Phase III 67 viral kinetic 67 Phase III Psoriasis 67 Phase lll 67 TRANSFORMS 67 Phase III clinical trials 67 Sprycel dasatinib 67 lintuzumab SGN 67 Phase 2b Clinical Trial 67 Actimmune ® 67 oxymorphone ER 67 evaluating Actimmune 67 Phase IIB clinical 67 pain palliation 67 TMC# C# 67 BCIRG 67 LUX Lung 67 Phase III ADT 67 Anturol TM 67 labial herpes 67 phase III ACCLAIM 67 multicenter randomized Phase 67 Genasense ® 67 lintuzumab 67 tesmilifene 67 Firazyr 67 enzastaurin 67 Octreolin 67 docetaxel Taxotere ® 67 PRIMO CABG 67 OVATURE 67 Cethrin 67 bardoxolone 67 II Clinical Trial 67 AEG# 67 Pyridorin 67 Initiates Phase II 67 rilonacept 67 IMPACT DCM 67 RAPTIVA 67 evaluating satraplatin 67 CEQ# 67 Allovectin 7 67 Phenoptin 67 ONCONASE R 67 COSIRA trial 67 bicifadine 67 PREOS 67 PD LID 67 Orazol 67 PRECISE Trial 67 rALLy 67 prospective multicenter randomized 67 Phase III randomized 67 Sorafenib HCC Assessment 67 teriflunomide 67 EOquin TM 67 Dextofisopam 67 landmark ATHENA 67 ganetespib 67 receptor tyrosine kinase inhibitor 67 Phase III Pivotal 67 AVERROES 67 ritonavir boosted danoprevir 67 prucalopride 67 randomized controlled clinical 67 refractory CLL 67 ocrelizumab 67 eniluracil 67 LEVADEX ™ 67 Evoltra ® 67 Fodosine 67 induced macular edema 67 oral FTY# 67 BENLYSTA ® 67 TACI Ig 67 midstage trials 67 Cloretazine 67 Ophena TM 67 TM Drug Eluting 67 Cimzia ® certolizumab pegol 67 SPRYCEL ® 67 Proellex TM 67 Phase IIA 67 fidaxomicin Phase 3 67 Initiated Phase 67 AMEVIVE 67 Virulizin ® 67 ADAGIO study 67 evaluating REVLIMID 67 Elagolix 67 generation purine nucleoside 67 Elocalcitol 67 ularitide 67 interferon beta 1b 67 Safinamide 67 nab paclitaxel 67 alemtuzumab Campath 67 GALNS 67 Cloretazine R 67 MERLIN TIMI 67 ritonavir boosted 67 FASLODEX 67 MADIT II 67 lexidronam injection 67 ORAL Sync 67 GW# [003] 67 Femara letrozole 67 registrational studies 67 Omacetaxine 67 pharmacokinetic PK 67 Icatibant 67 satraplatin Phase 67 AeroLEF TM 67 Evoltra TM 67 Ozarelix 67 Phase Ib clinical trials 67 Aloxi injection 67 clinical trial 67 ARCOXIA 67 inhibitor RG# 67 Completes Patient Enrollment 67 Nexavar sorafenib 67 docetaxel Taxotere R 66 reslizumab 66 Allovectin 7 ® 66 Zemplar Capsules 66 EmbraceAC 66 recurrent GBM 66 dexanabinol 66 TELINTRA 66 R#/MEM 66 CA9 SCAN 66 NEBIDO 66 ROTATEQ 66 oral prodrug 66 relapsing multiple sclerosis 66 CRMD# 66 elacytarabine 66 Telatinib 66 Betaferon ® 66 rasagiline tablets 66 FORTIS M 66 L BLP# 66 GOUT 66 Amoxicillin PULSYS Phase III 66 APTIVUS 66 multicentre randomized controlled 66 randomized multicenter trial 66 Onconase 66 ABSORB trial 66 Phase III trials 66 photoprotective drug 66 RIO Lipids 66 Neupro R 66 Cethrin R 66 CBLC# 66 prodrug stimulant 66 Saforis 66 TEMSO 66 eltrombopag 66 opioid induced bowel dysfunction 66 Multiple Ascending Dose 66 PRECISE trial 66 Phase III multicenter 66 XL# SAR# 66 tolevamer 66 IIa trials 66 velafermin 66 IMGN# 66 Immunotherapeutic 66 isavuconazole 66 HoFH 66 Randomized Phase II 66 dextromethorphan quinidine 66 VESTASYNC 66 MAA submission 66 TAXUS TM 66 Panzem R NCD 66 RhuDex 66 pralatrexate injection 66 refractory chronic lymphocytic 66 edoxaban 66 SYMMETRY trial 66 Fx #A 66 briakinumab 66 Troxatyl 66 Ixempra 66 SCENESSE ® 66 lorcaserin Phase 66 metastatic HRPC 66 Betaferon R 66 TELCYTA 66 Exherin TM 66 cilengitide 66 Taxotere ® 66 INSPIRE Trial Phase III 66 SNT-MC#/idebenone 66 Arzerra ofatumumab 66 Pirfenidone 66 Phase III ThermoDox 66 aclidinium bromide 66 MEND CABG II 66 NOX E# 66 HCD# [002] 66 antibody MAb 66 Certican 66 subcutaneously administered 66 BioSTAR R 66 CINTREDEKIN BESUDOTOX 66 Civacir 66 ATryn R 66 Myocet 66 EFAPROXYN 66 REMUNE R 66 TOLAMBA 66 mapatumumab 66 nonclinical studies 66 atacicept 66 ruxolitinib 66 ThermoDox R 66 metastatic CRC 66 PHASE III 66 orBec 66 HQK 66 Egrifta 66 RECORD1 66 ATL# [001] 66 Phase #/#a trial 66 REVIVE Diabetes 66 trastuzumab emtansine T DM1 66 EGS# 66 PRESEPT 66 Onrigin 66 Altastaph 66 multicenter multinational 66 Stedivaze 66 HGS ETR2 66 pitavastatin 66 PROMACTA 66 nalbuphine ER 66 MGd 66 Dyloject TM 66 Onalta ™ 66 telaprevir dosing 66 Randomized controlled 66 preclinical efficacy 66 ATTRACT 66 prospective multicentre 66 double blinded randomized 66 Bronchitol 66 methylnaltrexone 66 Phase III ALLEGRO 66 AVASTIN 66 GLPG# 66 ExTRACT TIMI 66 CIMZIA TM 66 BAY #-# 66 Canvaxin 66 BST CarGel R 66 Phase III TRIST 66 PDX pralatrexate 66 afamelanotide 66 DU #b 66 Mipomersen 65 ACTEMRA TM 65 ofatumumab 65 miconazole Lauriad ® 65 Drug Eluting Stent System 65 miconazole Lauriad R 65 R# #mg BID 65 Trandolapril 65 Phase II 65 ABSORB clinical 65 thetreatment 65 EOquin 65 PRTX 65 #I TM# 65 Trovax 65 FlutiformTM 65 Pazopanib 65 Tykerb lapatinib 65 European Sepsis Trial 65 adult chronic ITP 65 Marketing Authorisation Application MAA 65 MAXY alpha 65 Velcade bortezomib 65 hypoxia activated prodrug 65 Tavocept 65 ZOLINZA 65 diarrhea predominant irritable 65 Phase IIb Clinical Trial 65 GENASIS clinical 65 Kepivance 65 PrevOnco ™ 65 Somatuline R Depot 65 cetuximab Erbitux 65 Forodesine HCl 65 ALGRX 65 XIENCE V Stent System 65 Deforolimus 65 GLP toxicology studies 65 SEPET TM 65 TBC# 65 Natalizumab 65 OncoVex 65 Vicriviroc 65 IMC #B 65 bortezomib Velcade 65 Dacogen decitabine 65 prospective multicenter 65 APPRAISE 65 regorafenib 65 VELCADE melphalan 65 Enzastaurin 65 AEGR 65 Phase 2b monotherapy 65 Aplidin R 65 CIMZIA ™ 65 recurrent glioma 65 Tasimelteon 65 IND submission 65 Aurexis 65 Neupogen ® 65 fidaxomicin Phase 65 StemEx R 65 Randomized Evaluation 65 Increlex ® 65 MyVax R 65 dacetuzumab 65 OncoVEX GM CSF 65 IIa clinical 65 RELOVAIR ™ 65 controlled multicenter Phase 65 ALSYMPCA 65 REVLIMID lenalidomide 65 Augment Injectable 65 ONTARGET 65 PEGylated interferon beta 1a 65 incyclinide 65 trastuzumab DM1 T DM1 65 MOZOBIL 65 CRLX# 65 MYCAMINE 65 R#/MEM # 65 CoFactor 65 TRISENOX 65 Temsirolimus 65 Xerecept 65 Tracleer r 65 glucokinase activator 65 HuMax TAC 65 ofatumumab HuMax CD# 65 REMINYL ® 65 PROVENGE ® 65 RRMS patients 65 GTC recombinant human 65 Prospective Randomized 65 viral kinetics 65 adecatumumab MT# 65 maximally tolerated dose 65 EXPLORE Xa 65 TMC# [002] 65 null responder HCV 65 sorafenib Nexavar 65 tezampanel NGX# 65 ® natalizumab 65 tremelimumab 65 randomized multicenter 65 ROCKET AF 65 EVIZON TM 65 PEARL SC 65 urocortin 2 65 OPT CHF 65 miconazole Lauriad 65 SCIB1 65 metastatic castrate resistant 65 POSIDUR TM 65 Achieves Primary Endpoint 65 T Pred 65 Phase III confirmatory 65 Initiates Enrollment 65 MoxDuo IR 65 Aplidin 65 metastatic sarcomas 65 BLA submission 65 treatment naïve genotype 65 LCP Tacro 65 unblinding 65 Severe Sepsis 65 Angiox ® 65 adalimumab Humira 65 LIALDA 65 Ereska 65 MEK inhibitor 65 MKC# MT 65 terlipressin 65 PDE4 inhibitor 65 CALGB 65 clinicaltrials 65 pharmacodynamic effects 65 CAELYX 65 GSK# [001] 65 tramiprosate ALZHEMED TM 65 CLIRS trial 65 lapatinib Tykerb 65 Ceflatonin 65 virus HCV protease inhibitor 65 AIMM trial 65 BrachySil TM 65 ENRICH trial 65 PROSTVAC ® 65 NEVO 65 trodusquemine 65 pharmacokinetics PK 65 Azilect ® 65 trial evaluating PRX# 65 valopicitabine 65 Nexavar ® 65 pediatric pontine glioma 65 symptomatic BPH 65 investigational hepatitis C 65 mRCC 65 ALN VSP Phase 65 Xanafide 65 VIRAMUNE XR 65 OMNARIS Nasal Spray 65 Dalbavancin 65 Neulasta R 65 dose cohorts 65 Revlimid lenalidomide 65 IV Busulfex 65 Voraxaze ™ 65 IIa clinical trial 65 Omnitarg 65 novel histone deacetylase 65 AIR CF1 65 Hsp# Inhibitor 65 Rhucin R 65 PEG PAL 65 dosing cohort 65 Bezielle 65 BCX# 65 Randomized Study 65 pomalidomide 65 BRAF inhibitor 65 Phase 2a Study 65 DermaVir Patch 65 varespladib 65 Evoltra 65 CAMMS# 65 CERVARIX 65 TEMODAL 65 Tezampanel 65 oral salmon calcitonin 65 Investigational Device Exemption IDE 65 Prosaptide 65 glufosfamide 65 ospemifene 65 initiated Phase 1b 65 sorafenib tablets 65 romidepsin 65 albiglutide 65 DSMB recommended 65 dosing cohorts 65 Pafuramidine 65 Solazed 65 KIACTA ™ 65 OvaRex R 65 active comparator 65 Phase Ib IIa clinical 65 Medidur TM FA 65 pediatric neuroblastoma 65 AIR CF2 65 HuMax CD# 65 investigational protease inhibitor 64 Viprinex TM 64 Phase IIa clinical trials 64 nucleotide analog 64 cell lymphoma CTCL 64 visilizumab 64 TAXUS Element Stent System 64 Testosterone MDTS ® 64 LibiGel ® 64 PERSEUS clinical program 64 Soliris eculizumab 64 CCR5 antagonist 64 TO AVOID PREGNANCY WHILE 64 ACTIVE W 64 R sorafenib tablets 64 Dasatinib 64 oral picoplatin 64 HORIZONS AMI 64 paclitaxel Taxol R 64 NSABP C 64 NDA Submission 64 CTAP# Capsules 64 Glypromate 64 olaparib 64 UVIDEM 64 TheraCIM 64 Laquinimod 64 Ranolazine 64 RoACTEMRA 64 novel oral anticoagulant 64 Erbitux cetuximab 64 Triolex 64 Telbivudine 64 eritoran 64 Adjuvant Treatment 64 stated Michelle Berrey 64 CCX# B 64 MIRCERA 64 systemic anaplastic large 64 acute HAE attacks 64 Proxinium TM 64 Silodosin 64 Alocrest 64 velafermin belinostat 64 AVOREN 64 volociximab 64 evaluating mipomersen 64 bevirimat Study 64 Neo Bladder Augment 64 intravenous methylnaltrexone 64 arzoxifene 64 ZYBRESTAT fosbretabulin 64 Zerenex 64 StemEx 64 E1 INT TM 64 OHR/AVR# 64 Phase III registrational 64 Inc. NASDAQ BPAX 64 IRESSA 64 Evoltra R 64 masked placebo controlled 64 randomized Phase 64 AVONEX ® 64 Val HeFT 64 PEGINTRON TM 64 CYT# potent vascular disrupting 64 Vascular Wrap TM 64 randomized blinded 64 INCB# [002] 64 biliary tract cancer 64 PHX# 64 cobiprostone 64 Xeloda ® 64 AERx iDMS 64 Prodarsan 64 TransVax TM 64 RE LY 64 omega interferon 64 ZYBRESTAT 64 BNC# 64 gemcitabine Gemzar ® 64 PSN# [002] 64 talactoferrin 64 QLT# 64 subanalysis 64 custirsen 64 candidates Dyloject TM 64 Tesmilifene 64 rotigotine transdermal patch 64 PEG IFN 64 Neulasta ® 64 Increlex R 64 Neoadjuvant 64 Eliquis 64 TOCOSOL Paclitaxel 64 prospective observational 64 Acute Ischemic Stroke 64 ISTODAX 64 Xibrom TM 64 WILEX 64 Ketotransdel 64 AOD# [002] 64 rindopepimut 64 relapsed ALL 64 bendamustine 64 subcutaneous methylnaltrexone 64 salmeterol fluticasone 64 im peramivir 64 Afatinib 64 PROSTVAC TM 64 samalizumab 64 prulifloxacin 64 GRNVAC1 64 Trobalt 64 Phase 2a clinical trials 64 Spiegelmer ® 64 beta 1a 64 SUTENT 64 Deferiprone 64 CATIE AD 64 eprotirome 64 doxorubicin docetaxel 64 etanercept Enbrel 64 apaziquone 64 Vimpat ® lacosamide 64 Dupuytren Contracture 64 generation PNP inhibitor 64 GLP1 agonist 64 LymphoStat B belimumab 64 ACZ# 64 Hepatitis C HCV 64 JAK Inhibitor 64 RHUCIN 64 CCR5 mAb 64 COPERNICUS 64 EXPAREL ™ 64 ponatinib 64 squalamine 64 IMPACT DCM clinical 64 vernakalant hydrochloride 64 sitaxsentan 64 Oncoscience AG 64 inhaled AAT 64 ASSERT trial 64 Ocrelizumab 64 PEP# [003] 64 glatiramer acetate 64 Oxypurinol 64 RezularTM 64 Febuxostat 64 cinacalcet HCl 64 vosaroxin 64 recurrent NSCLC 64 vemurafenib 64 PreCISe 64 Gattex 64 pharmacodynamic PD 64 RE MODEL 64 BARACLUDE R 64 compound INCB# 64 Arimidex anastrozole 64 Cetrorelix 64 aclidinium 64 ancrod 64 PRECISE 64 non nucleoside inhibitor 64 R lenalidomide 64 Eluting Coronary Stent System 64 Board DSMB 64 Inhalation Solution 64 ANTEGREN 64 CHARM Added 64 Oncotype DX colon cancer 64 oropharyngeal candidiasis OPC 64 DDP# 64 Advaxis Phase 64 Specifid 64 Diamyd ® 64 cetrorelix pamoate 64 Cellegesic 64 ONTARGET R 64 OvaRex 64 ixabepilone 64 ThermoDox ® clinical 64 Shigamabs ® 64 Xelox 64 cediranib 64 metaglidasen 64 nucleoside analog 64 Cerebril TM 64 Serdolect ® 64 NV1FGF 64 PROVENGE sipuleucel T 64 icatibant 64 FAME Study 64 ENGAGE AF TIMI 64 Intravenous CP 64 Delcath Phase III 64 Triapine 64 ascending dose 64 clevudine 64 RH1 64 Phase 2a preventative